Novel biological properties of Oenothera paradoxa defatted seed extracts: Effects on metallopeptidase activity

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 17, 2008, Pages 7845-7852

  Kiss, Anna K ^a   Derwińska, Małgorzata ^a   Dawidowska, Anna ^a   Naruszewicz, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Aminopeptidase N; Angiotensin converting enzyme; Biological activity; Evening primrose; Metallopeptidases; Neutral endopeptidase; Oenothera paradoxa; Pentagalloylglucose; Polyphenols; Procyanidins

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; MICROSOMAL AMINOPEPTIDASE; PLANT EXTRACT;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; EVENING PRIMROSE; PLANT SEED;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIGENS, CD13; ENZYME INHIBITORS; METALLOPROTEASES; NEPRILYSIN; OENOTHERA; PLANT EXTRACTS; SEEDS;

OENOTHERA; OENOTHERA PARADOXA;

EID: 52649149813     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf801372h     Document Type: Article

References (40)

1. Newall, C. A.; Anderson, L. A.; Phillipson, J. D. Herbal Medicines, a Guide for Health-Care Professionals; The Pharmaceutical Press: London, U.K., 1996; pp 110-113.
2. Morse, N. L.; Clough, P. M. A meta-analysis of randomized, placebo-controlled clinical trails of Efamol® evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries? Curr. Pharma. Biotech. 2006, 7, 503-524.
3. Gail Darlington, L.; Stone, T. W. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br. J. Nutr. 2001, 85, 251-269.
4. Halat, K. M.; Dennehy, C. E. Botanicals and dietary supplements in diabetic peripheral neuropathy. J. Am. Board Family Practice 2003, 16, 47-57.
5. Briggs, C. J. Evening primrose. Rev. Pharm. Canad. 1986, 119, 249-254.
6. Hatano, T.; Yasuhara, T.; Matsuda, M.; Yazaki, K.; Yoshida, T.; Okuda, T. Oenothein B, a dimeric hydrolizable tannin of cyclic structure. Chem. Pharm. Bull. 1989, 37, 2269-2271.
7. Taniguchi, S.; Imayoshi, Y.; Yabu-uchi, R.; Ito, H.; Hatano, T.; Yoshida, T. A macrocyclic ellagitannin trimer, oenothein T1, from Oenothera sp. Phytochemistry. 2002, 59, 191-195.
8. Yoshida, T.; Chou, T.; Shingu, T.; Okuda, T.; Oenotheins, D, F., G. hydrolysable tannin dimers from Oenothera laciniata. Phytochemistry. 1995, 40, 555-561.
9. Howard, G.; Mabry, T. J.; Raven, P. H. Distribution of flavonoids in twenty-one species of Oenothera. Phytochemistry. 1972, 11, 289-291.
10. Zinsmeister, H. D.; Plitzko, I.; Schels, H. Flavonols glycosides in South American species of Oenothera sect. Oenothera. Phytochemistry. 1977, 16, 497.
11. Zinsmeister, H. D.; Bartl, S. The phenolic compounds of Oenothera. Phytochemistry. 1971, 10, 3129-3132.
12. Pellegrina, C. D.; Padovani, G.; Mainente, F.; Zoccatelli, G.; Bissoli, G.; Mosconi, S.; Veneri, G.; Peruffo, A.; Andrihetto, G.; Rizzi, C.; Chignola, R. Anti-tumor potential of a gallic acid-containing phenolic fraction from Oenothera biennis. Cancer Lett. 2005, 226, 17-25.
13. Arimura, T.; Kojima-Yuasa, A.; Suzuki, M.; Kennedy, D. O.; Matsui-Yuasa, I. Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Lett. 2003, 201, 9-16.
14. Arimura, T.; Kojima-Yuasa, A.; Kennedy, D. O.; Matsui-Yuasa, I. Reactive oxygen species-independent G1 arrest induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Lett. 2004, 207, 19-25.
15. Bałasińska, B.; Troszyńska, A. Total antioxidative activity of evening primrose Oenothera paradoxa) cake extract measured in vitro by liposome model and murine L1210 cells. J. Agric. Food Chem. 1998, 46, 3558-3563.
16. Wettasinghe, M.; Shahidi, F. Evening primrose meal: a source of natural antioxidants and scavenger of hydrogen-derived free radicals. J. Agric. Food Chem. 1999, 47, 1801-1812.
17. Birch, A. E.; Fenner, G. P.; Watkins, R.; Boyd, L. C. Antioxidant properties of evening primrose seed extracts. J. Agric. Food Chem. 2001, 49, 4502-4507.
18. Wettasinghe, M.; Shahidi, F.; Amarowicz, R. Identification and quantification of low molecular weight phenolic antioxidants in seeds of evening primrose (Oenothera biennis L.). J. Agric. Food Chem. 2002, 50, 1267-1271.
19. Wettasinghe, M.; Shahidi, F. Iron (II) chelation activity of extracts of borage and evening primrose meals. Food Res. Int. 2002, 35, 65-71.
20. Peschel, W.; Dieckmann, W.; Sonnenschein, M.; Peschel, A. High antioxidant potential of pressing residues from evening primrose in comparison to other oilseed cakes and plant antioxidant. Ind. Crops Prod. 2007, 25, 44-54.
21. Lu, F.; Foo, L. Y. Phenolic Antioxidant Components of Evening Primrose. Nutrition, Lipids, Health, and Disease; Niki, E., Packer, L., Eds.; AOCS Press: Champaign, IL, 1995; pp 86-95.
22. Corti, R.; Burnett, J. C.; Rouleau, J. L.; Ruschitzka, F.; Lüscher, T. F. A new therapeutic concept in cardiovascular disease? Circulation 2001, 104, 1856-1862.
23. Burnett, J. C. Vasopeptidase inhibition: a new concept in blood pressure management. J. Hypertens. 1999, 17, S37-S43.
24. Turner, A. J. Exploring the structure and function of zinc metallopeptidases: old enzyme and new discoveries. Biochem. Soc. Trans. 2003, 31, 723-727.
25. Turner, A. J.; Tanzawa, K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 1997, 11, 355-364.
26. Saiki, I.; Fujii, H.; Yoneda, J.; Abe, F.; Nakajima, M.; Tsuruo, T.; Azuma, I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer. 1993, 54, 137-143.
27. Shimizu, T.; Tani, K.; Hase, K.; Ogawa, H.; Huang, L.; Shinomiya, F.; Sone, S. CD13/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 2002, 46, 2330-2338.
28. Kiss, A.; Kowalski, J.; Melzig, M. F. Compounds from Epilobium angustifolium L. inhibit the specific metallopeptidases ACE, NEP and APN. Planta Med. 2004, 70, 919-923.
29. Guyot, S.; Marnet, N.; Laraba, D.; Sanoner, P.; Drilleau, J. Reversed-phase HPLC followed by thiolysis for quantitative estimation and characterization of the four main classes of phenolic compounds in different tissue zones of a French cider apple variety (Malus domestica Var. Kemerrien). J. Agric. Food Chem. 1998, 46, 1698-1705.
30. Packer, L.; Rimbach, G.; Virgili, F. Antioxidant and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radical Biol. Med. 1999, 27, 704-724.
31. Lui, J-C.; Tsai, J-C.; Chan, P.; Lui, J. Y-H.; Thomas, G. N.; Tomlinson, B.; Lo, M-Y.; Lin, J-Y. Antihypertensive effects of tannins isolated from Chinese herbs as non-specific inhibitors of angiotensin converting enzyme. Life Sci. 2003, 73, 1543-1555.
32. Jerez, M.; Pinelo, M.; Sineiro, J.; Núnez, M. J. Influence of extraction conditions on phenolic yields from pine bark: assessment of procyanidins polymerization degree by thiolysis. Food Chem. 2006, 94, 406-414.
33. Wagner, H.; Elbl, G. ACE-inhibitory procyanidins from Lespedeza capitata. Planta Med. 1992, 58, 297.
34. Actis-Goretta, L.; Ottaviani, J. I.; Keen, C. L.; Fraga, C. G. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett. 2003, 555, 597-600.
35. Inikuchi, J-I.; Okabe, H.; Yamauchi, T.; Nagamatsu, A.; Nonaka, G-I.; Nishioka, I. Antihypertensive substance in seeds of Areca catechu. Life Sci. 1986, 38, 1375-1382.
36. 1 receptor by proanthocyanidins from Guazuma ulmifolia bark. Planta Med. 2002, 68, 1066-1071.
37. Kim, S. H.; Kang, K. W.; Kim, K. W.; Kim, N. D. Procyanidins in crataegus extract evoke endotelium- dependent vasorelaxation in rat aorta. Life Sci. 2000, 67, 121-131.
38. Hunyadi, J.; Simon, M., Jr.; Kenderessy, A. S.; Dobozy, A. Expression of monocyte/macrophage markers (CD13, CD14, CD68) on human keratinocytes in health and diseased skin. J. Dermatol. 1993, 20, 341-345.
39. Gabrilovac, J.; Čupić, B.; Breljak, D.; Zekušić, M.; Boronić, M. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes. Immunol. Lett. 2004, 91, 39-47.
40. Thielitz, A.; Reinhold, D.; Vetter, R.; Bank, V.; Helmuth, M.; Halting, R.; Wrenger, S.; Wiswedel, I.; Lendechel, V.; Kähie, T.; Neubert, K.; Faust, J.; Zouboulis, Ch.C.; Ansorge, S.; Gollnick, H. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation. J. Invest. Dermatol. 2007, 127, 1042-1051.